Patent details

92508 Product Name: Cabozantinib et toutes les formes thérapeutiquement équivalentes qui en dérivent telles que protégées par le brevet de base, y compris les sels pharmaceutiquement acceptables

Basic Information

Publication number:
92508
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP101605186
Legal Status:
Active
Application number:
92508
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/13/890/001-001-003
Marketing Authorization Type:
Marketing Authorization Date:
26/03/2014
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
25/07/2014
First Marketing Authorization date:
26/03/2014
Grant date:
02/11/2015
Activation date:
24/09/2024
Publication date:
02/11/2015
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
26/03/2029
SPC Extension Expiration:
26/03/2029
Rejection date:
Withdrawal date:

Owner

From:
25/07/2014
 
 

Name:
EXELIXIS, INC.
Address:
210 EAST GRAND AVENUE, PO Box 511, SOUTH SAN FRANCISCO, CA 94080-0511, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
25/07/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Bannen Lynne Canne
Address:
United States (US)

2

Name:
Forsyth Timothy Patrick
Address:
United States (US)

3

Name:
Wang Yong
Address:
United States (US)

4

Name:
Nuss John M.
Address:
United States (US)

5

Name:
Mac Morrison B.
Address:
United States (US)

6

Name:
Xu Wei
Address:
United States (US)

7

Name:
Parks Jason Jevious
Address:
United States (US)

8

Name:
Mann Larry W.
Address:
United States (US)

9

Name:
Leahy James William
Address:
United States (US)

10

Name:
Chan Diva Sze-Ming
Address:
United States (US)

11

Name:
Khoury Richard George
Address:
United States (US)

Publication

Bulletin

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
23
Annual Fee Amount:
430 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/09/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages